Opterion successfully secures EUR 8.4m Bridge Financing Round
· Opterion Health AG has secured commitments to raise EUR 8.4m to fund its final preclinical activities to create a new standard in Peritoneal Dialysis (PD) and prepare for Phase I · The capital round funded by a small group of professional private and institutional investors from Switzerland and Germany, was oversubscribed by over 40% · The company is also relocating its offices to Muttenz (BL), becoming part of the life science ecosystem of the Basel areaSarnen, Switzerland, 19 January 2021 – Opterion Health AG, a preclinical Swiss life science company, developing the first